Cormedix Inc (CRMD)
5.19
-0.14
(-2.63%)
USD |
NASDAQ |
Apr 25, 16:00
5.185
0.00 (0.00%)
After-Hours: 20:00
Cormedix Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 98.63% |
| September 30, 2022 | 78.45% |
| June 30, 2022 | 98.44% |
| March 31, 2022 | 80.00% |
| December 31, 2021 | 14.88% |
| September 30, 2021 | 33.93% |
| June 30, 2021 | -76.12% |
| March 31, 2021 | 30.50% |
| December 31, 2020 | -2.72% |
| September 30, 2020 | 14.09% |
| June 30, 2020 | -16.67% |
| March 31, 2020 | 34.48% |
| December 31, 2019 | -86.15% |
| September 30, 2019 | -32.75% |
| June 30, 2019 | 40.09% |
| March 31, 2019 | -38.65% |
| December 31, 2018 | 16.62% |
| September 30, 2018 | 16.13% |
| June 30, 2018 | -345.8% |
| Date | Value |
|---|---|
| March 31, 2018 | -23.12% |
| December 31, 2017 | |
| September 30, 2017 | -9.13% |
| June 30, 2017 | 86.74% |
| March 31, 2017 | -136.5% |
| December 31, 2016 | 29.89% |
| September 30, 2016 | 1.19% |
| June 30, 2016 | -1.03K% |
| March 31, 2016 | -21.25% |
| December 31, 2015 | -615.6% |
| September 30, 2015 | 1.53% |
| June 30, 2015 | 15.15% |
| March 31, 2015 | 44.60% |
| December 31, 2014 | -222.3% |
| September 30, 2014 | 30.06% |
| June 30, 2014 | -37.13% |
| March 31, 2014 | -564.0% |
| December 31, 2013 | -9.98K% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-86.15%
Minimum
Dec 2019
98.63%
Maximum
Dec 2022
20.61%
Average
30.50%
Median
Mar 2021
Gross Profit Margin (Quarterly) Benchmarks
| BioXcel Therapeutics Inc | -89.89% |
| Assertio Holdings Inc | 70.53% |
| Verastem Inc | -- |
| Ocular Therapeutix Inc | 90.64% |
| PAVmed Inc | -53.57% |